SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001665160-23-000746
Filing Date
2023-04-24
Accepted
2023-04-24 15:20:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 9440
2 offeringmemoformc.pdf EX-99 34889290
  Complete submission text file 0001665160-23-000746.txt   48055698
Mailing Address 2155 E CONFERENCE DR STE 115 STE 115 TEMPE AZ 85284
Business Address 2155 E CONFERENCE DR. STE 115 TEMPE AZ 85284 480-939-5770
iMetabolic Biopharma Corp (Filer) CIK: 0001957114 (see all company filings)

IRS No.: 823644889 | State of Incorp.: NV | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-31493 | Film No.: 23839811